What is GELS's relative strength rating?

GELS ranks at the 6th percentile over 1 month, 85th percentile over 3 months, 21th percentile over 6 months, 12th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is GELS in?

GELS is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is GELS in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). GELS benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is GELS?

GELS currently shows a 20-day average daily range (ADR%) of 10.7%, a 90-day beta versus the S&P 500 of 5.92. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does GELS have a seasonal pattern?

TickerStance computes GELS's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what GELS has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did GELS last report earnings?

No SEC EDGAR filings are linked to GELS in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Gelteq Limited Ordinary Shares (GELS) · RS 21

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Gelteq Limited Ordinary Shares (GELS) has a 3-month relative strength percentile of 85 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 10.7%, relative volume 0.44×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month85pctile

6 month21pctile

1 year12pctile

Classic25IBD pctile

LDR6leadership

0 of 5 lenses lit · avg RS pctile 30

✓ADR%10.7%✓A/DA!RVOL0.44×!$ Vol$2M

COMPUTED · AS OF 2026-08-24

Pattern read

GELS is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -18.0% / -29.7%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

1 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

6

3m

85

6m

21

1y

12

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · GELS

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
GELS
85RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

IBRXImmunityBio, Inc. Common Stock21 EIKNEikon Therapeutics, Inc. Common Stock21 GRIGRI Bio, Inc. Common Stock21 HROWHarrow, Inc. Common Stock22

§ Seasonality

10y · since 2024

Best monthApr on averageavg +50.23% · 50% win · n 2

Worst monthAug on averageavg -27.63% · 0% win · n 1

GELS monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	GELS Jan avg: 9.12% median: 9.12% win: 50% σ: 17.17% n: 2 2024-10-30 → 2026-07-31	GELS Feb avg: -24.56% median: -24.56% win: 0% σ: 3.61% n: 2 2024-10-30 → 2026-07-31	GELS Mar avg: -24.61% median: -24.61% win: 0% σ: 16.93% n: 2 2024-10-30 → 2026-07-31	GELS Apr avg: 50.23% median: 50.23% win: 50% σ: 74.46% n: 2 2024-10-30 → 2026-07-31	GELS May avg: -24.18% median: -24.18% win: 0% σ: 0.01% n: 2 2024-10-30 → 2026-07-31	GELS Jun avg: 22.57% median: 22.57% win: 100% σ: 20.43% n: 2 2024-10-30 → 2026-07-31	GELS Jul avg: -11.19% median: -11.19% win: 0% σ: 15.82% n: 2 2024-10-30 → 2026-07-31	GELS Aug avg: -27.63% median: -27.63% win: 0% σ: 0.00% n: 1 2024-10-30 → 2026-07-31 (current)	GELS Sep avg: 10.22% median: 10.22% win: 100% σ: 0.00% n: 1 2024-10-30 → 2026-07-31	GELS Oct avg: -13.71% median: -13.71% win: 0% σ: 1.11% n: 2 2024-10-30 → 2026-07-31	GELS Nov avg: -15.17% median: -15.17% win: 0% σ: 9.48% n: 2 2024-10-30 → 2026-07-31	GELS Dec avg: -4.96% median: -4.96% win: 50% σ: 29.65% n: 2 2024-10-30 → 2026-07-31

Public attention · GELS

Is the crowd watching?

44/ 100 · vs its own 90-day norm▲ 7 vs 7dStealth leader

Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Gelteq Limited (GELS) Edges Lower to $0.56 as Support at $0.53 Comes into Focus - Fibonacci Extension - vinanet.vn · vinanet.vn

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float5.1Mshares

Shares out10.7Mshares

Market cap$5.7MNano Cap

FAQ

Frequently asked questions

What is GELS's relative strength rating?: GELS ranks at the 6th percentile over 1 month, 85th percentile over 3 months, 21th percentile over 6 months, 12th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is GELS in?: GELS is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is GELS in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). GELS benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is GELS?: GELS currently shows a 20-day average daily range (ADR%) of 10.7%, a 90-day beta versus the S&P 500 of 5.92. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does GELS have a seasonal pattern?: TickerStance computes GELS's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what GELS has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Gelteq Limited Ordinary Shares (GELS) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

Gelteq Limited Ordinary Shares (GELS) — Stance & relative strength

GELS is on the watchlist, not confirmed. 3m RS is 85, Market Stance is mixed at 47.8, A/D rating A

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?